Clinical trial data company Beaconcure eyes US expansion
Beaconcure’s platform Verify is designed to review clinical trial datasets and pinpoint inconsistencies.
By
Beaconcure’s platform Verify is designed to review clinical trial datasets and pinpoint inconsistencies.
ByNeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial to…
ByThe company anticipates reporting topline data from the trial in the second half of this year.
The trial will recruit 140 patients with biopsy-confirmed NASH.
J&J’s booster given after Pfizer-BioNTech’s two-dose regimen led to a continued rise of antibodies for a minimum of four weeks.
The data showed 62% statistically significant reduction in mortality and 21% efficacy benefit with opaganib.
Understanding the sudden increase in confirmed Covid-19 cases in Israel will help contain the virus and avoid a fourth lockdown.
ByThe trial will assess the safety and efficacy of Allocetra given along with the standard of care in a total…